Skip to main content
AstraZeneca PLC logo

AstraZeneca PLC — Investor Relations & Filings

Ticker · AZN ISIN · GB0009895292 LEI · PY6ZZQWO2IZFZC3IOL08 IL Manufacturing
Open in API
Filings indexed 3,304 across all filing types
Latest filing 2023-08-01 Foreign Filer Report
Country GB United Kingdom
Listing IL AZN

About AstraZeneca PLC

https://www.astrazeneca.com/

AstraZeneca PLC is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines. The company's portfolio is concentrated on several main therapy areas, including Oncology; Cardiovascular, Renal & Metabolism; and Respiratory & Immunology. AstraZeneca is committed to advancing healthcare through a robust research and development pipeline, aiming to deliver innovative medicines that address significant unmet medical needs for millions of patients worldwide. The company leverages scientific innovation to transform the future of healthcare and improve patient outcomes.

Recent filings

Filing Released Lang Actions
TOTAL VOTING RIGHTS
Foreign Filer Report
2023-08-01 English
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is a notification released via RNS (the news service of the London Stock Exchange) on August 1, 2023. The content explicitly states it is made in accordance with the UK Financial Conduct Authority's Disclosure and Transparency Rule 5.6.1 and provides the total number of voting rights (1,549,886,092) as of July 31, 2023. This type of filing, which reports on the total issued share capital and voting rights, is a standard regulatory disclosure. While it relates to capital structure, it is not a formal capital change announcement (SHA) or a director's dealing (DIRS). Since it is a specific regulatory disclosure concerning voting rights and capital structure published through the RNS system, and it doesn't fit perfectly into the other specific categories like DIV or CAP, it aligns best with the general regulatory announcement category, RNS, or potentially DVA (Declaration of Voting Results & Voting Rights Announcements). Given the explicit mention of 'Voting rights and capital' and the reference to the Disclosure and Transparency Rule, DVA is the most precise fit among the provided options, as it deals directly with voting rights information.
2023-08-01 English
FORM 6K
Foreign Filer Report
2023-07-28 English
ALEXION ENTERS GENE THERAPY AGREEMENT WITH PFIZER
Foreign Filer Report
2023-07-28 English
Alexion enters gene therapy agreement with Pfizer
M&A Activity Classification · 1% confidence The document is clearly identified as an RNS (Regulatory News Service) announcement, indicated by the 'RNS Number' header and the concluding statement: 'This information is provided by RNS, the news service of the London Stock Exchange.' The content details a significant corporate transaction—Alexion/AstraZeneca acquiring a gene therapy portfolio from Pfizer—which is a material event requiring immediate public disclosure. Since this is a general regulatory announcement of a material event that doesn't fit the specific categories like M&A (TAR), Financing (CAP), or Director's Dealing (DIRS), the most appropriate classification is the general regulatory filing category, RNS.
2023-07-28 English
Half-year Report
Earnings Release Classification · 1% confidence The document text contains detailed financial summaries for 'H1 and Q2 2023 results', including revenue, EPS figures, growth rates, commentary from the CEO, pipeline updates, and guidance for FY 2023. It explicitly mentions 'Interim dividend maintained' and provides comprehensive financial tables for the half-year (H1) and the second quarter (Q2). This structure is characteristic of a comprehensive financial report covering a period shorter than a full year, which aligns with the definition of an Interim/Quarterly Report (IR). It is not merely an announcement of a report (RPA/RNS) because it contains the full results data, nor is it the Annual Report (10-K). H1 2023
2023-07-28 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.